Form 4: Celcuity Inc. Director Richard Nigon Acquires Stock Options
SEC Form 4 Filing
Director Richard Nigon acquired 14,048 stock options in Celcuity Inc. on May 19, 2025, according to a Form 4 filing.
Summary
- Richard Nigon, a director of Celcuity Inc., filed a Form 4 disclosing a transaction involving derivative securities.
- On May 19, 2025, Nigon acquired 14,048 stock options with an exercise price of $10.69.
- These options vest on April 30, 2026, or the date of the Company's 2026 Annual Meeting of Stockholders, and expire on May 19, 2035.
- The filing also includes a Power of Attorney, authorizing Griffin D. Foster, Jonathan R. Zimmerman, Sheremy R. Anderson, and Amra Hoso to act on Nigon's behalf for SEC filings related to Celcuity Inc. securities.
Sentiment
Score: 6
Explanation: The document itself is neutral, simply reporting a transaction. The acquisition of options by a director could be interpreted as a mildly positive signal, suggesting confidence in the company's prospects, but it's a routine filing.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of stock options, which is a common form of executive compensation.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the biotechnology industry, aligning management's interests with those of shareholders.
- The vesting schedule and exercise price are typical for such grants, designed to incentivize long-term value creation.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 2024-12-09 | Date of execution of the Power of Attorney. |
| 2025-05-19 | Date of transaction: acquisition of stock options. |
| 2025-05-21 | Date of filing of the Form 4. |
| 2026-04-30 | Vesting date of the stock options, or the date of the Company's 2026 Annual Meeting of Stockholders, if earlier. |
| 2035-05-19 | Expiration date of the stock options. |
Keywords
Form 4, stock options, derivative securities, Richard Nigon, Celcuity Inc., director, acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.